PPD and Lovelace Biomedical and Environmental Research Institute Enter into Collaboration

July 14, 2010 By: NCTechNews Category: Pharmaceuticals

(Wilmington, N.C.) PPD, Inc. (Nasdaq: PPDI) and Lovelace Biomedical and Environmental Research Institute (LBERI) today announced they have entered into a collaboration focused on future service opportunities for biopharmaceutical and government clients across a range of therapeutic areas.

Under the collaboration, the companies plan to refer to one another potential business opportunities for laboratory, preclinical and clinical development services they do not offer to their respective clients. In addition, the companies intend to work together to collaborate and jointly bid on select new research projects.

“As demand for preclinical services grows, our collaboration with LBERI builds on our strong capabilities and competitive position, particularly in the areas of respiratory, infectious diseases, health outcomes and epidemiology,” said David Grange, chief executive officer of PPD. “This collaboration also enables us to broaden our work with government organizations through LBERI’s existing government relationships.”

Robert Rubin, Ph.D., president and chief executive officer of Lovelace Respiratory Research Institute, of which LBERI is a subsidiary, added, “Aligning with one of the world’s leading CROs allows us to build on our 65-plus year history of discovery research, public health advancement and extensive preclinical service offerings. With PPD, we can expand our already strong laboratory, preclinical and clinical development capabilities to meet future health challenges.”

About PPD

PPD is a leading global contract research organization, celebrating 25 years of providing drug discovery, development and lifecycle management services. Our clients and partners include pharmaceutical, biotechnology, medical device, and academic and government organizations. With offices in 41 countries and more than 10,500 professionals worldwide, PPD applies innovative technologies, therapeutic expertise and a commitment to quality to help clients and partners accelerate the delivery of safe and effective therapeutics and maximize the returns on their R&D investments. For more information, visit www.ppdi.com.

About Lovelace

Lovelace Biomedical and Environmental Research Institute and its family of companies is a 65-year-old, not-for-profit biomedical research institute dedicated to improving the public health through cutting-edge research on the causes, new treatments and molecular mechanisms of disease. The Institutes specialize in drug development; environmental science, clinical and health outcomes investigations; defense studies and respiratory disease research. Lovelace Biomedical and Environmental Research Institute (LBERI) is a subsidiary of Lovelace Respiratory Research Institute (LRRI). LRRI is based in Albuquerque, N.M., employs 1,100 people, and is a $125 million company. For more information, visit www.lrri.org.

Comments are closed.

  • Controlling Quality

    An RTP firm is gaining international notoriety as a leader in analytical instrumentation for the pharmaceutical and chemical manufacturing industries, sharing innovative solutions to evolving pharmaceutical and chemical manufacturing challenges, presenting on emerging multi-variant approaches to obtaining immediate, unambiguous results from drug product samples at a recent major international tradeshow.

    Portable Power

    Alternative energy solutions provider INI Power Systems, Inc. recently marked its ten-year anniversary by unveiling the innovative new Trinity™ series of portable alternative energy hybrid solutions at two major events catering to the defense and emergency first responder marketplaces, with attendees searching for reliable, flexible power systems with multiple applications.

    EV Innovation

    Morrisville-based green transportation pioneer Evatran™ recently hosted a demonstration of its Plugless Power™ hands-free electric vehicle (EV) charging system, showcasing cost savings and convenience of EV usage in residential, commercial and public applications.

    guide to success

    Entrepreneurs now have a workbook to guide them through successful implementation of business building blocks thanks to a new goal-setting toolkit for personal and professional success available at no charge from a Cary-based international strategic business consultant.

    Packaging Cures

    RTP-based advertising and branding firm The Marketing Machine helped overcome the issue of illiteracy among medical patients in Ghana, South Africa in designing packaging for the only manufacturer of anti-retroviral drugs in the region, creating individual icons and colors to help patients understand which drugs they needed, regardless of their ability to read.

    Broadband Stimulus

    Two grants funded by the American Recovery and Reinvestment Act are being used by MCNC to expand broadband connectivity and services throughout North Carolina and create more than 1,000 engineering and construction jobs, the organization said.

  • Recent Headlines



free web site traffic and promotion